GO:0050585 4-hydroxymandelate synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050585 (4-hydroxymandelate synthase activity) catalyzes the oxidative decarboxylation of 4-hydroxyphenylpyruvate to 4-hydroxymandelate and CO2.
• The enzyme is a mononuclear non-heme Fe(II)-dependent dioxygenase that performs a four-electron oxidation, distinguishing it from related two-electron hydroxylases.
• 4-Hydroxymandelate synthase (HMS) is structurally and mechanistically related to 4-hydroxyphenylpyruvate dioxygenase (HPPD), but the two enzymes diverge in their reaction outcomes.
• The catalytic cycle involves substrate binding, decarboxylation, and benzylic hydroxylation, with the Fe(II) center activating dioxygen.
• HMS is involved in the biosynthesis of 4-hydroxymandelate, a precursor for benzaldehyde and other aromatic compounds, and has biotechnological potential.
• Research on HMS informs enzyme engineering, chiral hydroxylation, and the design of CRISPR-based cell models for metabolic pathway studies.
Description
4-Hydroxymandelate synthase (HMS) is a mononuclear non-heme iron enzyme that catalyzes the conversion of 4-hydroxyphenylpyruvate (4-HPP) to 4-hydroxymandelate and carbon dioxide. This reaction, classified under GO:0050585, represents a four-electron oxidation that is mechanistically distinct from the two-electron hydroxylations carried out by many related enzymes. HMS is part of the biosynthetic pathway leading to 4-hydroxymandelate, a compound that serves as a precursor for benzaldehyde and other aromatic metabolites in certain bacteria. Understanding HMS is important for researchers studying non-heme iron enzymology, chiral hydroxylation, and the evolution of catalytic function within the HPPD-like family. The enzyme's ability to perform benzylic hydroxylation with high stereoselectivity has attracted interest for biocatalytic applications. Moreover, HMS provides a model system for investigating how gene duplication and catalytic divergence can generate new enzymatic activities. In this article, we explore the definition, mechanism, structural features, key genes, and research methods associated with GO:0050585, with a focus on how CRISPR-based models can be used to study its function and regulation.
4-hydroxymandelate synthase activity At A Glance
| GO ID | GO:0050585 |
|---|---|
| GO term | 4-hydroxymandelate synthase activity |
| Ontology | molecular_function |
| Synonym | 4-hydroxyphenylpyruvate dioxygenase II activity; 4-hydroxyphenylpyruvate:oxygen oxidoreductase (decarboxylating) |
| Major function | Catalyzes the oxidative decarboxylation of 4-hydroxyphenylpyruvate to 4-hydroxymandelate and CO2 |
| Cofactor | Mononuclear non-heme Fe(II) |
| Reaction type | Four-electron oxidation |
| Substrate | 4-Hydroxyphenylpyruvate |
| Product | 4-Hydroxymandelate |
What Is GO:0050585?
GO:0050585, 4-hydroxymandelate synthase activity, is defined as the catalysis of the reaction: 4-hydroxyphenylpyruvate + O2 = 4-hydroxymandelate + CO2. This molecular function is carried out by enzymes that use a mononuclear non-heme Fe(II) center to activate dioxygen and perform an oxidative decarboxylation coupled to hydroxylation. The term is synonymous with 4-hydroxyphenylpyruvate dioxygenase II activity and 4-hydroxyphenylpyruvate:oxygen oxidoreductase (decarboxylating).
Why Is 4-hydroxymandelate synthase activity Important in Cell Biology?
GO:0050585 is important because it defines a unique enzymatic activity that bridges primary metabolism and specialized aromatic compound biosynthesis. The enzyme 4-hydroxymandelate synthase (HMS) is a member of the non-heme iron dioxygenase family, which includes medically and biotechnologically relevant enzymes such as HPPD. HMS catalyzes a four-electron oxidation, a reaction that is less common than two-electron hydroxylations and provides insights into how enzymes control reaction outcomes. The product, 4-hydroxymandelate, is a chiral building block that can be converted to benzaldehyde and other high-value chemicals. Understanding HMS also sheds light on the evolutionary relationship between HPPD and HMS, which arose from gene duplication and catalytic divergence. From a biomedical perspective, HMS is not directly linked to human disease, but its mechanism informs the study of related human enzymes and the development of enzyme inhibitors. Furthermore, HMS serves as a model for engineering stereoselective hydroxylation, which is valuable in pharmaceutical synthesis.
• Provides a textbook example of a four-electron oxidation by a mononuclear non-heme Fe(II) enzyme.
• Catalyzes the formation of 4-hydroxymandelate, a precursor for benzaldehyde and other aromatic compounds.
• Offers a paradigm for understanding catalytic divergence within the HPPD-like enzyme family.
• Enables stereoselective benzylic hydroxylation, relevant for chiral synthesis.
• Serves as a target for enzyme engineering to produce value-added chemicals.
• Informs mechanistic studies of related human enzymes such as HPPD.
• Facilitates research on non-heme iron enzymology and oxygen activation.
• Supports the development of CRISPR-based cell models for metabolic pathway analysis.
What Happens During 4-hydroxymandelate synthase activity?
Substrate Binding and Oxygen Activation
In simple terms: The enzyme grabs its substrate and activates oxygen to start the reaction.
The catalytic cycle begins with the binding of 4-hydroxyphenylpyruvate (4-HPP) to the mononuclear non-heme Fe(II) center of HMS. The Fe(II) ion is coordinated by a facial triad of two histidines and one glutamate (or aspartate), leaving open coordination sites for substrate and dioxygen. Upon substrate binding, the Fe(II) center becomes poised to activate molecular oxygen, forming a ferric-superoxo intermediate. This step is critical for the subsequent oxidative decarboxylation and hydroxylation.
Decarboxylation and Hydroxylation
In simple terms: The enzyme removes a carboxyl group as CO2 and adds a hydroxyl group to the side chain.
Following oxygen activation, the reaction proceeds through a decarboxylation step that releases CO2 and generates a ferryl (Fe(IV)=O) intermediate. This high-valent iron species then abstracts a hydrogen atom from the benzylic position of the substrate, leading to hydroxylation and formation of 4-hydroxymandelate. Computational studies have elucidated the energy landscape of this mechanism, highlighting the role of the ferryl intermediate in both decarboxylation and hydroxylation. The overall reaction is a four-electron oxidation, distinguishing HMS from related two-electron hydroxylases.
Product Release and Enzyme Turnover
In simple terms: The product leaves the enzyme, allowing it to start another cycle.
After the hydroxylation step, 4-hydroxymandelate is released from the active site, and the Fe(II) center returns to its resting state. Structural studies of HMS from Amycolatopsis orientalis in complex with 4-hydroxymandelate have provided snapshots of the product-bound state, revealing key interactions that stabilize the product and facilitate its release. The enzyme is then ready for another round of catalysis.
Key Genes Involved in GO:0050585 4-hydroxymandelate synthase activity
The following genes and proteins are directly or indirectly associated with 4-hydroxymandelate synthase activity (GO:0050585) and its related pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| hms | Encodes 4-hydroxymandelate synthase in Amycolatopsis orientalis | Structural and mechanistic studies |
| hppD | Encodes 4-hydroxyphenylpyruvate dioxygenase, a related enzyme | Comparative mechanism and evolution |
| hpgT | Involved in 4-hydroxyphenylglycine biosynthesis in Herpetosiphon aurantiacus | Gene duplication and catalytic divergence |
| hmo | Encodes 4-hydroxymandelate oxidase in related pathways | Benzaldehyde production |
| hpaB | Encodes 4-hydroxyphenylacetate 3-monooxygenase | Aromatic compound degradation |
| hpaC | Encodes a reductase component of 4-hydroxyphenylacetate 3-monooxygenase | Biocatalysis |
| tyrA | Involved in tyrosine biosynthesis, upstream of 4-HPP | Metabolic engineering |
| tyrB | Tyrosine aminotransferase, produces 4-HPP | Substrate supply |
| aspC | Aspartate aminotransferase, can produce 4-HPP | Metabolic engineering |
| aroG | DAHP synthase, aromatic amino acid biosynthesis | Flux control |
| pheA | Chorismate mutase/prephenate dehydratase | Phenylalanine biosynthesis |
| adh | Alcohol dehydrogenase, may reduce 4-hydroxymandelate | Product conversion |
| aldh | Aldehyde dehydrogenase, oxidizes benzaldehyde | Benzaldehyde production |
| hms-like | Putative HMS homologs in other bacteria | Functional prediction |
| fe(II)-binding proteins | Non-heme iron enzymes with similar folds | Mechanistic comparison |
| hppD-like | HPPD-like dioxygenases | Evolutionary studies |
| 4-HPP pathway genes | Genes for 4-HPP synthesis and utilization | Pathway engineering |
How Is 4-hydroxymandelate synthase activity Regulated?
The regulation of 4-hydroxymandelate synthase activity is not well characterized at the transcriptional or post-translational level. In Amycolatopsis orientalis, the hms gene is likely part of a biosynthetic gene cluster for 4-hydroxymandelate or related metabolites, but specific regulators have not been identified. In Herpetosiphon aurantiacus, the hpgT gene, which encodes a homolog involved in 4-hydroxyphenylglycine biosynthesis, may be subject to pathway-specific regulation. Generally, non-heme iron enzymes can be regulated by iron availability and oxidative stress, but direct evidence for HMS regulation is lacking. Further research is needed to elucidate how HMS activity is controlled in vivo.
4-hydroxymandelate synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HPPD | Tyrosinemia type III, neurological disorders | HPPD knockout cell lines, point mutations |
| HMS (bacterial) | Not linked to human disease | Bacterial expression, enzyme assays |
| hpgT | Not linked to human disease | Gene knockout in Herpetosiphon |
| hpaB/hpaC | Not linked to human disease | Metabolic engineering in E. coli |
| tyrA/tyrB | Tyrosine metabolism disorders | Knockout in model organisms |
HMS and Human Disease: No Direct Link
There is no known direct association between 4-hydroxymandelate synthase activity (GO:0050585) and human disease. The enzyme is found in bacteria and is not encoded in the human genome. However, mechanistic studies of HMS can inform our understanding of related human enzymes, such as 4-hydroxyphenylpyruvate dioxygenase (HPPD), which is involved in tyrosine metabolism and is linked to diseases like tyrosinemia type III. HPPD deficiency in humans leads to neurological symptoms, and understanding the catalytic mechanism of HPPD-like enzymes can aid in the development of therapeutic inhibitors.
Biotechnological and Industrial Relevance
HMS is of interest for biotechnological applications, particularly in the production of benzaldehyde and other aromatic aldehydes. Engineered Escherichia coli strains expressing mutant HMS have been used to convert L-phenylalanine to benzaldehyde, demonstrating the potential of HMS in metabolic engineering. Additionally, HMS can be used for the stereoselective synthesis of chiral hydroxylated compounds, which are valuable in the pharmaceutical industry. These applications highlight the importance of HMS research beyond human health.
From 4-hydroxymandelate synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of HMS? | Point mutations in hms gene, enzyme kinetics |
| How does HMS achieve stereoselectivity? | Knock-in of mutant hms, chiral analysis |
| What is the role of HMS in benzaldehyde production? | Overexpression of hms in E. coli |
| How did HMS evolve from HPPD? | Knockout and complementation with hppD/hms |
| What are the structural determinants of substrate specificity? | Tagged knock-in for crystallography |
| Can HMS be engineered for new substrates? | Directed evolution, library screening |
How to Study the 4-hydroxymandelate synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzyme kinetics | Catalytic activity, Km, kcat | Characterization of HMS variants |
| UV-visible spectroscopy | Substrate consumption, product formation | Routine activity assays |
| EPR spectroscopy | Iron oxidation state, radical intermediates | Mechanistic studies |
| X-ray crystallography | Three-dimensional structure | Active site analysis |
| DFT calculations | Reaction energetics, intermediates | Mechanism elucidation |
| Metabolic engineering | Product yield, pathway flux | Benzaldehyde production |
| CRISPR knockout | Gene function, pathway disruption | Model construction |
| Chiral analysis | Enantiomeric excess | Stereoselectivity assessment |
Enzyme Kinetics and Spectroscopic Assays
Enzyme kinetics are used to measure the catalytic activity of HMS, typically by monitoring the consumption of 4-hydroxyphenylpyruvate or the formation of 4-hydroxymandelate. Spectroscopic methods such as UV-visible absorption, electron paramagnetic resonance (EPR), and Mössbauer spectroscopy can probe the electronic structure of the Fe(II) center and reaction intermediates. These techniques are essential for understanding the mechanism of oxygen activation and substrate turnover.
Structural Biology
X-ray crystallography has been used to determine the structure of HMS from Amycolatopsis orientalis in complex with 4-hydroxymandelate, revealing the active site architecture and substrate binding mode. Structural comparisons with HPPD have provided insights into the structural basis for catalytic divergence. Cryo-electron microscopy and NMR may also be applicable for studying HMS dynamics.
Computational Modeling
Density functional theory (DFT) calculations have been employed to elucidate the reaction mechanism of HMS, including the formation of the ferryl intermediate and the hydroxylation step. Computational studies complement experimental data and help predict the effects of mutations on catalysis. Molecular dynamics simulations can provide insights into substrate binding and protein dynamics.
Metabolic Engineering and Synthetic Biology
HMS can be expressed in heterologous hosts such as Escherichia coli to produce 4-hydroxymandelate or benzaldehyde. Metabolic engineering strategies involve optimizing codon usage, promoter strength, and pathway flux. CRISPR-based genome editing can be used to knock out competing pathways or knock in HMS variants to improve product yield.
How CRISPR Can Be Used to Study GO:0050585 4-hydroxymandelate synthase activity
Knockout
CRISPR-Cas9 knockout of hms or related genes in bacterial or eukaryotic models can be used to study the physiological role of 4-hydroxymandelate synthase activity. For example, knocking out hms in Amycolatopsis orientalis would abolish 4-hydroxymandelate production, allowing researchers to confirm its biosynthetic function. In heterologous hosts, knockout of competing pathways can increase flux toward the desired product.
Point Mutation
CRISPR-mediated point mutations can be introduced into the hms gene to probe the catalytic mechanism. For instance, mutating the iron-coordinating residues (e.g., His and Glu/Asp) would abolish activity, while mutations in the substrate-binding pocket could alter substrate specificity or stereoselectivity. Such mutants are valuable for structure-function studies.
Knock-in
Knock-in of hms or its variants into a heterologous host can enable the production of 4-hydroxymandelate or downstream compounds. CRISPR can be used to insert the hms gene under a strong promoter or to replace a native gene with a mutant version. This approach is useful for metabolic engineering and for studying the enzyme in a controlled genetic context.
Overexpression
CRISPR activation (CRISPRa) or plasmid-based overexpression can be used to increase HMS levels in cells. Overexpression is often employed to enhance product yield in biotechnological processes. It can also be used to study the effects of HMS on cellular metabolism and to produce sufficient protein for structural and biochemical studies.
How EDITGENE Supports 4-hydroxymandelate synthase activity Research
Researchers studying 4-hydroxymandelate synthase activity-related genes often need to determine whether a candidate gene is causally involved in the pathway, how mutations affect enzyme function, and whether the gene can be engineered for biotechnological applications. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for 4-hydroxymandelate synthase activity research.
Frequently Asked Questions About 4-hydroxymandelate synthase activity
What is 4-hydroxymandelate synthase activity?
It is the enzymatic activity defined by GO:0050585 that catalyzes the conversion of 4-hydroxyphenylpyruvate to 4-hydroxymandelate and CO2.
What genes are involved in 4-hydroxymandelate synthase activity?
The primary gene is hms, which encodes the enzyme in bacteria such as Amycolatopsis orientalis. Related genes include hppD and hpgT.
What is the mechanism of 4-hydroxymandelate synthase?
It uses a mononuclear non-heme Fe(II) center to activate oxygen, forming a ferryl intermediate that performs decarboxylation and benzylic hydroxylation.
Is 4-hydroxymandelate synthase related to human disease?
No direct link to human disease is known, but it is structurally and mechanistically related to human HPPD, which is involved in tyrosinemia.
How can I study 4-hydroxymandelate synthase activity?
Enzyme kinetics, spectroscopy, crystallography, and computational modeling are common methods.
Can CRISPR be used to study 4-hydroxymandelate synthase?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression can be used to manipulate hms and related genes.
What is the product of 4-hydroxymandelate synthase?
The product is 4-hydroxymandelate, a chiral compound used as a precursor for benzaldehyde and other chemicals.
What are the synonyms for 4-hydroxymandelate synthase activity?
Synonyms include 4-hydroxyphenylpyruvate dioxygenase II activity and 4-hydroxyphenylpyruvate:oxygen oxidoreductase (decarboxylating).
How does 4-hydroxymandelate synthase differ from HPPD?
HMS catalyzes a four-electron oxidation to produce 4-hydroxymandelate, while HPPD produces homogentisate via a similar but distinct mechanism.
What are the biotechnological applications of 4-hydroxymandelate synthase?
It is used for the production of benzaldehyde and chiral hydroxylated compounds.
Conclusion
GO:0050585, 4-hydroxymandelate synthase activity, represents a fascinating example of a mononuclear non-heme iron enzyme that performs a four-electron oxidation to produce 4-hydroxymandelate. While not directly linked to human disease, HMS serves as a valuable model for understanding enzyme mechanism, evolution, and biocatalysis. The availability of CRISPR-based tools for gene editing and model generation will continue to advance research on this enzyme and its applications.
References
- 1. Takakura Y et al.. 2022. Efficient enzymatic production of benzaldehyde from l-phenylalanine with a mutant form of 4-hydroxymandelate synthase.. Biosci Biotechnol Biochem 86(12):1718-1725 PMID: 36214415
- 2. Di Giuro CM et al.. 2013. Chiral hydroxylation at the mononuclear nonheme Fe(II) center of 4-(S) hydroxymandelate synthase--a structure-activity relationship analysis.. PLoS One 8(7):e68932 PMID: 23935907
- 3. Wójcik A et al.. 2012. Mechanism of benzylic hydroxylation by 4-hydroxymandelate synthase. A computational study.. Biochemistry 51(47):9570-80 PMID: 23126679
- 4. Brownlee J et al.. 2008. Two roads diverged: the structure of hydroxymandelate synthase from Amycolatopsis orientalis in complex with 4-hydroxymandelate.. Biochemistry 47(7):2002-13 PMID: 18215022
- 5. Peck SC et al.. 2017. Go it alone: four-electron oxidations by mononuclear non-heme iron enzymes.. J Biol Inorg Chem 22(2-3):381-394 PMID: 27783267
- 6. Wu P et al.. 2025. Engineering Escherichia coli for the S-selective production of 2-hydroxyisovalerate.. Biodes Res 7(4):100059 PMID: 42038709
- 7. Borowski T et al.. 2004. 4-Hydroxyphenylpyruvate dioxygenase: a hybrid density functional study of the catalytic reaction mechanism.. Biochemistry 43(38):12331-42 PMID: 15379572
- 8. Kastner S et al.. 2012. 4-Hydroxyphenylglycine biosynthesis in Herpetosiphon aurantiacus: a case of gene duplication and catalytic divergence.. Arch Microbiol 194(6):557-66 PMID: 22307823
